These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 33078731)
1. Mangiferin ameliorates intracerebroventricular-quinolinic acid-induced cognitive deficits, oxidative stress, and neuroinflammation in Wistar rats. Arora MK; Kisku A; Jangra A Indian J Pharmacol; 2020; 52(4):296-305. PubMed ID: 33078731 [TBL] [Abstract][Full Text] [Related]
2. Plumbagin Alleviates Intracerebroventricular-Quinolinic Acid Induced Depression-like Behavior and Memory Deficits in Wistar Rats. Kumar Arora M; Ratra A; Asdaq SMB; Alshamrani AA; Alsalman AJ; Kamal M; Tomar R; Sahoo J; Ashok J; Imran M Molecules; 2022 Mar; 27(6):. PubMed ID: 35335195 [TBL] [Abstract][Full Text] [Related]
3. Mangiferin ameliorates aluminium chloride-induced cognitive dysfunction via alleviation of hippocampal oxido-nitrosative stress, proinflammatory cytokines and acetylcholinesterase level. Kasbe P; Jangra A; Lahkar M J Trace Elem Med Biol; 2015; 31():107-12. PubMed ID: 26004900 [TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of naringin, a flavone glycoside in quinolinic acid-induced neurotoxicity: Possible role of PPAR-γ, Bax/Bcl-2, and caspase-3. Cui J; Wang G; Kandhare AD; Mukherjee-Kandhare AA; Bodhankar SL Food Chem Toxicol; 2018 Nov; 121():95-108. PubMed ID: 30130594 [TBL] [Abstract][Full Text] [Related]
5. Sertraline and venlafaxine improves motor performance and neurobehavioral deficit in quinolinic acid induced Huntington's like symptoms in rats: Possible neurotransmitters modulation. Gill JS; Jamwal S; Kumar P; Deshmukh R Pharmacol Rep; 2017 Apr; 69(2):306-313. PubMed ID: 28178592 [TBL] [Abstract][Full Text] [Related]
6. Minocycline modulates neuroprotective effect of hesperidin against quinolinic acid induced Huntington's disease like symptoms in rats: behavioral, biochemical, cellular and histological evidences. Kumar A; Chaudhary T; Mishra J Eur J Pharmacol; 2013 Nov; 720(1-3):16-28. PubMed ID: 24211676 [TBL] [Abstract][Full Text] [Related]
7. Hesperidin and Silibinin Ameliorate Aluminum-Induced Neurotoxicity: Modulation of Antioxidants and Inflammatory Cytokines Level in Mice Hippocampus. Jangra A; Kasbe P; Pandey SN; Dwivedi S; Gurjar SS; Kwatra M; Mishra M; Venu AK; Sulakhiya K; Gogoi R; Sarma N; Bezbaruah BK; Lahkar M Biol Trace Elem Res; 2015 Dec; 168(2):462-71. PubMed ID: 26018497 [TBL] [Abstract][Full Text] [Related]
8. Improvement of mitochondrial function by paliperidone attenuates quinolinic acid-induced behavioural and neurochemical alterations in rats: implications in Huntington's disease. Mishra J; Kumar A Neurotox Res; 2014 Nov; 26(4):363-81. PubMed ID: 24752928 [TBL] [Abstract][Full Text] [Related]
9. Protective effect of montelukast against quinolinic acid/malonic acid induced neurotoxicity: possible behavioral, biochemical, mitochondrial and tumor necrosis factor-α level alterations in rats. Kalonia H; Kumar P; Kumar A; Nehru B Neuroscience; 2010 Nov; 171(1):284-99. PubMed ID: 20813166 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of resveratrol against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats. Kumar A; Naidu PS; Seghal N; Padi SS Pharmacology; 2007; 79(1):17-26. PubMed ID: 17135773 [TBL] [Abstract][Full Text] [Related]
11. Non-steroidal anti-inflammatory agents, tolmetin and sulindac attenuate quinolinic acid (QA)-induced oxidative stress in primary hippocampal neurons and reduce QA-induced spatial reference memory deficits in male Wistar rats. Dairam A; Müller AC; Daya S Life Sci; 2007 Mar; 80(15):1431-8. PubMed ID: 17266991 [TBL] [Abstract][Full Text] [Related]
12. L-theanine prevent quinolinic acid induced motor deficit and striatal neurotoxicity: Reduction in oxido-nitrosative stress and restoration of striatal neurotransmitters level. Jamwal S; Singh S; Gill JS; Kumar P Eur J Pharmacol; 2017 Sep; 811():171-179. PubMed ID: 28624333 [TBL] [Abstract][Full Text] [Related]
13. Tempol and perindopril protect against lipopolysaccharide-induced cognition impairment and amyloidogenesis by modulating brain-derived neurotropic factor, neuroinflammation and oxido-nitrosative stress. Ali MR; Abo-Youssef AM; Messiha BA; Khattab MM Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):637-56. PubMed ID: 27026404 [TBL] [Abstract][Full Text] [Related]
15. Protective Effect of Spermidine Against Excitotoxic Neuronal Death Induced by Quinolinic Acid in Rats: Possible Neurotransmitters and Neuroinflammatory Mechanism. Jamwal S; Singh S; Kaur N; Kumar P Neurotox Res; 2015 Aug; 28(2):171-84. PubMed ID: 26078029 [TBL] [Abstract][Full Text] [Related]
16. Mangiferin prevents corticosterone-induced behavioural deficits via alleviation of oxido-nitrosative stress and down-regulation of indoleamine 2,3-dioxygenase (IDO) activity. Luo GQ; Liu L; Gao QW; Wu XN; Xiang W; Deng WT Neurol Res; 2017 Aug; 39(8):709-718. PubMed ID: 28403684 [TBL] [Abstract][Full Text] [Related]
17. Resveratrol abrogates alcohol-induced cognitive deficits by attenuating oxidative-nitrosative stress and inflammatory cascade in the adult rat brain. Tiwari V; Chopra K Neurochem Int; 2013 May; 62(6):861-9. PubMed ID: 23422878 [TBL] [Abstract][Full Text] [Related]
18. Improvement of mitochondrial NAD(+)/FAD(+)-linked state-3 respiration by caffeine attenuates quinolinic acid induced motor impairment in rats: implications in Huntington's disease. Mishra J; Kumar A Pharmacol Rep; 2014 Dec; 66(6):1148-55. PubMed ID: 25443748 [TBL] [Abstract][Full Text] [Related]
19. Suppression of methylglyoxal hyperactivity by mangiferin can prevent diabetes-associated cognitive decline in rats. Liu YW; Zhu X; Yang QQ; Lu Q; Wang JY; Li HP; Wei YQ; Yin JL; Yin XX Psychopharmacology (Berl); 2013 Aug; 228(4):585-94. PubMed ID: 23529380 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of cyclooxygenase inhibitors on intracerebroventricular colchicine-induced dysfunction and oxidative stress in rats. Kumar A; Seghal N; Padi SV; Naidu PS Eur J Pharmacol; 2006 Dec; 551(1-3):58-66. PubMed ID: 17027965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]